Overdiagnosis in cancer (2010)

Peer-Reviewed Study · Welch HG, Black WC · May 5, 2010

Welch HG et al., 2010-05-05: Review quantifying overdiagnosis from randomised screening trials: about 25% of mammographically detected breast cancers, 50% of chest x-ray/sputum-detected lung cancers and 60% of PSA-detected prostate cancers would not have gone on to cause symptoms or death.

We estimated the magnitude of overdiagnosis from randomized trials: about 25% of mammographically detected breast cancers, 50% of chest x-ray and/or sputum-detected lung cancers, and 60% of prostate-specific antigen-detected prostate cancers.

p.605 (Abstract)

Welch HG et al., 2010-05-05: Review quantifying overdiagnosis from randomised screening trials: about 25% of mammographically detected breast cancers, 50% of chest x-ray/sputum-detected lung cancers and 60% of PSA-detected prostate cancers would not have gone on to cause symptoms or death. No funding or disclosure statement in the MEDLINE record. No product; review. Supports scepticism about survival statistics as evidence of cure, but it is about screening-detected disease, not about chemotherapy's effect on already-diagnosed cancer – the book should not use it as if it were the latter. Study type: review.